Replies to post #11263 on Synaptogenix Inc (SNPX)

[runncoach]

Not sure how many shares scientists in the field buy but no doubt loser failed MOAs ruin it for the small cap bios. Luckily good science can over come generalities as we have recently seen.

[redspinelpinktopaz]

"too good to be true" is what we said about Arrowhead when it was four, even though the science said it was true. Now it is 27. The science says Neurotrope is true. Patience.

[Theburg]

Investor2014, investors have been following “the experts in the field” for decades and have lost fortunes doing so.
Do you have a bear case against the possible success of this trial outside of your previous post?

[SF Wolf]

It is always nice to have an "altruistic" skeptic point out the flaws in the investment thesis of committed investors in a particular stock. Thanks for trying to save us from our own folly!

But the first question that runs through my mind is are they even a stockholder, followed by are they betting in the option market on failure, or are they short the stock, or maybe they have a hidden agenda with some hedge fund.

In the case of Neurotrope it seems that Investor2014 and the other gadflies
on the board also are wagering on another horse in the race to find an effective treatment for AD.